Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating topical 5-fluorouracil effervescent powder for the treatment of vitiligo; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical 5-Fluorouracil (5-fluorouracil)

Snippet

Sponsor: Al-Azhar University | Conditions: Vitiligo, Topical Fluorouracil | Phase 4 | Status: RECRUITING